Moreover, in colorectal cancer, METTL3 targets genes such as SOX2, HK2, SLC2A1, and CBX8, inducing metastasis-related processes and activating the glycolysis pathway and cellular stemness (34–36). This evidence concerns the gene CBX8 and colorectal cancer.